[Diabetes-talk] Sanofi's Insulin Drug (Lantus) Raises Cancer Risk, Study Shows

[Everett Gavel]

FYI,
Everett


"Sanofi's insulin drug raises cancer risk, study shows.
Sanofi's (SNY) Lantus, the world's leading insulin drug
with annual sales of $4.7B, almost triples the risk of
developing cancer among diabetics, a Swedish study
shows. Sanofi dismissed the research as being flawed
and too small."
(www.bloomberg.com/news/2011-12-06/sanofi-s-lantus-doub
led-risk-of-cancer-in-study-of-diabetics-study-finds.ht
ml)